This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v0.2.0: STU 1 Ballot 2) based on FHIR R4. . For a full list of available versions, see the Directory of published versions

(DRAFT) Potential Drug-Drug Interaction (PDDI) CDS IG : Ballot for Comment 2
Defining URL:http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone-exclude
Version:0.2.0
Name:Valueset_rimexolone_exclude
Status:draft
Title:Exclude Rimexolone Medications Value Set
Definition:

ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.

Publisher:PDDI CDS
Copyright:

Attribution CC BY

Source Resource:XML / JSON / Turtle
This value set is used by:

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://www.nlm.nih.gov/research/umls/rxnorm version 02-Jul-2018
    CodeDisplay
    207446rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]
    365826rimexolone Ophthalmic Suspension [Vexol]
    199115rimexolone 10 MG/ML Ophthalmic Suspension
    379299rimexolone Ophthalmic Suspension
    1157440rimexolone Ophthalmic Product
    1188083Vexol Ophthalmic Product

Expansion

This value set contains 6 concepts

Expansion based on RxNorm version ??

All codes from system http://www.nlm.nih.gov/research/umls/rxnorm

CodeDisplay
207446rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]
365826rimexolone Ophthalmic Suspension [Vexol]
199115rimexolone 10 MG/ML Ophthalmic Suspension
379299rimexolone Ophthalmic Suspension
1157440rimexolone Ophthalmic Product
1188083Vexol Ophthalmic Product